Published in J Asthma on May 07, 2013
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16
New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med (2011) 2.07
Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol (2002) 1.98
Burden of concomitant asthma and COPD in a Medicaid population. Chest (2008) 1.87
Association of asthma symptoms with peak particulate air pollution and effect modification by anti-inflammatory medication use. Environ Health Perspect (2002) 1.85
Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med (2014) 1.77
Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol (2003) 1.57
A regional comparison of mold spore concentrations outdoors and inside "clean" and "mold contaminated" Southern California buildings. J Occup Environ Hyg (2005) 1.55
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2014) 1.52
Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol (2011) 1.49
The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacks. J Allergy Clin Immunol (2012) 1.41
Response to Wolf [corrected] and Marks. J Allergy Clin Immunol (2005) 1.39
Potential benefits and problems with computerized prescriber order entry: analysis of a voluntary medication error-reporting database. Am J Health Syst Pharm (2006) 1.29
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med (2005) 1.24
Pest and allergen exposure and abatement in inner-city asthma: a work group report of the American Academy of Allergy, Asthma & Immunology Indoor Allergy/Air Pollution Committee. J Allergy Clin Immunol (2010) 1.11
Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med (2010) 1.10
An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm (2006) 1.09
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. Am J Manag Care (2008) 1.06
Parent-reported environmental exposures and environmental control measures for children with asthma. Arch Pediatr Adolesc Med (2002) 1.04
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis (2011) 1.02
Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting. Appl Health Econ Health Policy (2014) 0.98
Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database. Am J Manag Care (2010) 0.97
Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin (2010) 0.96
Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. Curr Med Res Opin (2009) 0.96
Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med (2008) 0.95
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. Health Serv Res (2008) 0.94
Risk factors and predictive clinical scores for asthma exacerbations in childhood. Chest (2010) 0.94
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clin Ther (2007) 0.93
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med (2010) 0.93
Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma. J Asthma (2010) 0.93
The positive predictive value of a hyperkalemia diagnosis in automated health care data. Pharmacoepidemiol Drug Saf (2010) 0.92
How and by whom care is delivered influences anti-inflammatory use in asthma: Results of a national population survey. J Allergy Clin Immunol (2003) 0.90
Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. Allergy Asthma Proc (2014) 0.89
Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol (2012) 0.89
Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients. Curr Med Res Opin (2010) 0.88
Methylated Genes in Sputum Among Older Smokers With Asthma. Chest (2012) 0.87
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 0.87
Can outpatient pharmacy data identify persons with undiagnosed COPD? Am J Manag Care (2010) 0.87
Overweight, race, and psychological distress in children in the Childhood Asthma Management Program. Pediatrics (2007) 0.86
Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management. J Med Econ (2011) 0.86
The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: patients' experience with allergen immunotherapy. Allergy Asthma Proc (2014) 0.85
Prevalence of Bartonella infection in domestic cats in Denmark. Vet Res (2002) 0.85
The impact of self-identified race on epidemiologic studies of gene expression. Genet Epidemiol (2011) 0.84
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol (2008) 0.84
Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis. Clin Ther (2010) 0.84
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf (2010) 0.84
Mometasone furoate versus beclomethasone dipropionate: effectiveness in patients with mild asthma. Am J Manag Care (2010) 0.83
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Am J Geriatr Pharmacother (2009) 0.82
Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res (2014) 0.82
Economic burden of chronic bronchitis in the United States: a retrospective case-control study. Int J Chron Obstruct Pulmon Dis (2011) 0.82
Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States. J Asthma (2010) 0.82
The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: provider practices and beliefs about allergen immunotherapy. Int Forum Allergy Rhinol (2014) 0.81
Latent variable mixture modeling: a flexible statistical approach for identifying and classifying heterogeneity. Nurs Res (2012) 0.81
Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patients. Ann Am Thorac Soc (2015) 0.81
A genome-wide association study of chronic obstructive pulmonary disease in Hispanics. Ann Am Thorac Soc (2015) 0.81
Development of the pediatric environmental health specialty unit network in North America. Am J Public Health (2009) 0.79
The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management. Prim Care Respir J (2010) 0.79
Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease. Am J Epidemiol (2013) 0.79
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Curr Med Res Opin (2009) 0.79
Features indicative of cervical abnormality. A factor to be reckoned with in clinical headache work and research? Funct Neurol (2004) 0.79
Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis. J Manag Care Spec Pharm (2015) 0.79
Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia. Value Health (2009) 0.78
Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population. Am J Geriatr Pharmacother (2012) 0.78
Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma. Prim Care Respir J (2010) 0.78
Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction. Chest (2015) 0.77
Persistent asthma defined using HEDIS versus survey criteria. Am J Manag Care (2010) 0.77
Influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia. Am J Health Syst Pharm (2008) 0.77
An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials. J Asthma (2010) 0.77
Clinical use of immunoassays in assessing exposure to fungi and potential health effects related to fungal exposure. Ann Allergy Asthma Immunol (2004) 0.77
Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes. Am J Manag Care (2011) 0.77
An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes . Curr Med Res Opin (2008) 0.77
Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients. Int J Chron Obstruct Pulmon Dis (2010) 0.77
A retrospective analysis of clinical characteristics, hospitalization, and functional outcomes in residents with and without Clostridium difficile infection in US long-term care facilities. Curr Med Res Opin (2014) 0.77
A retrospective comparison of acute rhinosinusitis outcomes in patients prescribed antibiotics, mometasone furoate nasal spray, or both. Am J Rhinol Allergy (2012) 0.76
The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis. Curr Med Res Opin (2010) 0.76
Validation and agreement across four versions of the asthma control questionnaire in patients with persistent asthma. Respir Med (2010) 0.76
Relationship between short-acting β2-adrenergic agonist use and healthcare costs. Am J Manag Care (2011) 0.76
Clinical outcomes, health resource use, and cost in patients with early versus late dual or triple anti-platelet treatment for acute coronary syndrome. Am J Cardiovasc Drugs (2013) 0.75
A cross-sectional retrospective analysis of the regionalization of complex surgery. BMC Surg (2014) 0.75
Reply from the authors. Am J Respir Crit Care Med (2014) 0.75
Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia. Ann Clin Psychiatry (2015) 0.75
Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population. Curr Med Res Opin (2009) 0.75
Asthma Severity in patients initiating controller monotherapy versus combination therapy. J Asthma (2011) 0.75
Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis. Allergy Asthma Proc (2016) 0.75
Effects of skilled nursing facility structure and process factors on medication errors during nursing home admission. Health Care Manage Rev (2014) 0.75
The status of asthma control in the U.S. adult population. Allergy Rhinol (Providence) (2010) 0.75
Validation of the AQLQ12+ among adolescents and adults with persistent asthma. Qual Life Res (2010) 0.75
Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice. J Manag Care Spec Pharm (2015) 0.75
Indicators of poorly controlled asthma and health-related quality of life among school-age children in the United States. Allergy Asthma Proc (2017) 0.75